E-LIB Suche - Ergebnisse für: Marshe, Victoria

1

W26. POLYGENIC RISK SCORE ANALYSIS OF ANTIDEPRESSANT TREATM..:

Magarbeh, Leen ; Islam, Farhana ; Elsheikh, Samar...
European Neuropsychopharmacology. 75 (2023) - p. S117-S118 , 2023

Link: https://doi.org/10.1016/..

2

Modelling Latent Environmental Modifiers of Polygenic Risk ..:

Elsheikh, Samar ; Marshe, Victoria ; Kennedy, James L....
Alzheimer's & Dementia. 19 (2023) S12 - p. , 2023

Link: https://doi.org/10.1002/..

3

F5. GENE-ENVIRONMENTAL MODIFIERS USING POLYGENIC RISK AND S..:

Elsheikh, Samar ; Marshe, Victoria ; Paré, Guillaume...
European Neuropsychopharmacology. 75 (2023) - p. S222-S223 , 2023

Link: https://doi.org/10.1016/..

4

Genomic Investigation of Remission and Relapse of Psychotic..:

Men, Xiaoyu ; Marshe, Victoria ; Elsheikh, Samar S....
Neuropsychobiology. 82 (2023) 3 - p. 168-178 , 2023

Link: https://doi.org/10.1159/..

5

GENOME-WIDE ANALYSIS OF THE CORRELATION BETWEEN ANTIDEPRESS..:

Elsheikh, Samar ; Marshe, Victoria ; Maciukiewicz, Malgorzata...
European Neuropsychopharmacology. 63 (2022) - p. e261-e262 , 2022

Link: https://doi.org/10.1016/..

6

P256. ABCB1 Gene Variants and Antidepressant Response and T..:

Magarbeh, Leen ; Choi, Maximilian ; Hassel, Claudia...
Biological Psychiatry. 91 (2022) 9 - p. S191 , 2022

Link: https://doi.org/10.1016/..

7

M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUC..:

Mueller, Daniel ; Kennedy, James ; Meltzer, Herbert...
Schizophrenia Bulletin. 46 (2020) Supplement_1 - p. S202-S202 , 2020

Link: https://doi.org/10.1093/..

8

S79. Predicting Venlafaxine Remission in Late-Life Depressi..:

Marshe, Victoria ; Maciukiewicz, Malgorzata ; Hauschild, Anne-Christin...
Biological Psychiatry. 85 (2019) 10 - p. S327-S328 , 2019

Link: https://doi.org/10.1016/..

9

GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE ..:

Maciukiewicz, Malgorzata ; Marshe, Victoria ; Hauschild, Anne-Christine...
European Neuropsychopharmacology. 29 (2019) - p. S843 , 2019

Link: https://doi.org/10.1016/..

10

T19DEVELOPING AND EVALUATING A STANDARDIZED, MACHINE LEARNI..:

Marshe, Victoria ; Hauschild, Anne-Christin ; Maciukiewicz, Malgorzata.
European Neuropsychopharmacology. 29 (2019) - p. S228-S229 , 2019

Link: https://doi.org/10.1016/..

11

M31 IMPACT OF CYP2C19 AND CYP2D6 GENE VARIANTS ON PLASMA LE..:

Islam, Farhana ; Marshe, Victoria ; Maciukiewicz, Malgorzata...
European Neuropsychopharmacology. 29 (2019) - p. S183 , 2019

Link: https://doi.org/10.1016/..

12

S124. Impact of CYP2C19 and CYP2D6 Genotypes on Clinical Ou..:

Islam, Farhana ; Marshe, Victoria ; Maciukiewicz, Malgorzata...
Biological Psychiatry. 85 (2019) 10 - p. S344-S345 , 2019

Link: https://doi.org/10.1016/..

13

GENOME-WIDE ANALYSES OF REMISSION ON VENLAFAXINE TREATMENT ..:

Mueller, Daniel ; Marshe, Victoria ; Maciukiewicz, Malgorzata...
European Neuropsychopharmacology. 29 (2019) - p. S1045-S1046 , 2019

Link: https://doi.org/10.1016/..

14

UNRAVELING GENOMIC CONTRIBUTIONS TO VENLAFAXINE REMISSION I..:

Marshe, Victoria ; Maciukiewicz, Malgorzata ; Rej, Soham...
European Neuropsychopharmacology. 29 (2019) - p. S865-S866 , 2019

Link: https://doi.org/10.1016/..

15

F42POST-GWAS IN SILICO BIOLOGICAL CHARACTERIZATION OF VARIA..:

Marshe, Victoria ; Maciukiewicz, Malgorzata ; Tiwari, Arun K....
European Neuropsychopharmacology. 29 (2019) - p. S1132 , 2019

Link: https://doi.org/10.1016/..